Concepedia

Publication | Closed Access

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

DOI

111

Citations

18

References

2014

Year

Matthew I. Milowsky, Christian Dittrich, Ignacio Durán, Satinder Jagdev, Frederick Millard, Christopher J. Sweeney, Dean F. Bajorin, Linda Cerbone, David I. Quinn, Walter M. Stadler,
European Journal of Cancer

References

YearCitations

Page 1